PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.01%
Revenue growth under 50% of WEED.TO's 12.80%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-129.16%
Negative gross profit growth while WEED.TO is at 20.49%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2648.08%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2648.08%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-1840.05%
Negative net income growth while WEED.TO stands at 30.07%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-1840.00%
Negative EPS growth while WEED.TO is at 39.72%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1840.00%
Negative diluted EPS growth while WEED.TO is at 39.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.63%
Share reduction more than 1.5x WEED.TO's 15.76%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.63%
Diluted share reduction more than 1.5x WEED.TO's 15.76%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-163.79%
Negative OCF growth while WEED.TO is at 58.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-178.99%
Negative FCF growth while WEED.TO is at 58.58%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
297.40%
5Y revenue/share CAGR 1.25-1.5x WEED.TO's 245.75%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-52.47%
Negative 3Y CAGR while WEED.TO stands at 131.01%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-297.77%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-3403.96%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
83.35%
Positive 3Y OCF/share CAGR while WEED.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-51280.40%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-2688.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-9959.44%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
6257.60%
10Y equity/share CAGR above 1.5x WEED.TO's 1322.83%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
29.59%
Positive 5Y equity/share CAGR while WEED.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-12.97%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-15.83%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-20.07%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-24.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.85%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.64%
R&D dropping or stable vs. WEED.TO's 18.64%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-11.81%
We cut SG&A while WEED.TO invests at 8.25%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.